Tag Archives: research

Association of German Supervisory Authorities issues paper on broad consent for research

On April 3, 2019, the Association of German Supervisory Authorities (“Datenschutzkonferenz” or “DSK”) issued a paper (available here in German) on the interpretation of “broad consent” for scientific research in Recital 33 of the GDPR and the interplay with the definition of consent  and the principle of purpose limitation. According to the DSK, broad consent … Continue Reading

UK Government Considering New Patient Data Security and Research Consent Standards, Sanctions

A new post on the Covington eHealth blog reports that the UK government is running a consultation around NHS patient data security standards and a new legal framework for secondary uses (e.g. research) of patient data.  To find out more about the proposals and the consultation, please click here.… Continue Reading

Covington at #SXSW 2015: MIT Professors “Tackle Privacy”

South by Southwest (“SXSW”) Interactive kicked off last week, and Covington was there once again to cover privacy.  One panel of interest that we attended, entitled “Data (in)Security: MIT Scientists Tackle Privacy,” featured MIT professors Danny Weitzner, Ronald Rivest, and Sam Madden discussing their current research and related privacy issues.  All three hail from MIT’s Computer … Continue Reading

HITECH Update #4: HHS Relaxes HIPAA Requirements for Research Authorizations

This post is part of our series on key aspects of the final HITECH omnibus rule issued by the U.S. Department of Health and Human Services (HHS) on January 17, 2013 (available here), and scheduled to be published in the Federal Register on January 25.  Previous posts are available here.  The regulations are effective March 26, 2013, … Continue Reading

Stanford Researcher Unveils Latest Internet Privacy Study

Jonathan Mayer of Stanford’s Center for Internet and Society unveiled the Center’s latest research report, “Tracking the Trackers: Where Everybody Knows Your Username,” at the National Press Club Tuesday morning. The event also featured remarks from Federal Trade Commission Chairman Jon Leibowitz and Senior Counsel to the U.S. Senate Committee on Commerce, Science and Transportation Christian Fjeld … Continue Reading

HIPAA/HITECH Regulations are Coming: What do Pharmaceutical Companies Need to Know? (Part 4 of 5)

This is the fourth in our series on provisions of the Department of Health and Human Services (HHS) proposed rule implementing the HITECH Act that, if included in the final rule, are likely to have the greatest impact on the business operations of pharmaceutical and other life sciences companies.  We previously covered HHS’s proposed treatment … Continue Reading

HIPAA/HITECH Regulations are Coming: What do Pharmaceutical Companies Need to Know? (Part 3 of 5)

In this third post on the forthcoming HIPAA/HITECH regulations, we will discuss potential modifications to the rules regarding authorization for future research.  In earlier posts, we covered the Department of Health and Human Service’s (HHS) proposed treatment of communications about currently prescribed drugs and remunerated treatment communications.  Future Research In the proposed rule issued last July, … Continue Reading